Dasatinib impairs long-term expansion of leukemic progenitors in a subset of acute myeloid leukemia cases

Por Han, Lina, Schuringa, Jan Jacob, Mulder, André, Vellenga, Edo
Publicado em 2010

Understanding the functional difference between growth arrest-specific protein 6 and protein S: an evolutionary approach

Por Studer, Romain A., Opperdoes, Fred R., Nicolaes, Gerry A. F., Mulder, André B., Mulder, René
Publicado no Open Biol (2014)

High protein S activity due to C4b‐binding protein deficiency in a 34‐year‐old Surinamese female with ischemic retinopathy

Por Mulder, René, de Vries, Jeroen K., Müskens, Rogier P.H.M., Mulder, André B., Lukens, Michaël V.
Publicado no Clin Case Rep (2018)

Anemia at pediatric intensive care unit discharge: prevalence and risk markers

Por Demaret, Pierre, Karam, Oliver, Tucci, Marisa, Lacroix, Jacques, Behal, Hélène, Duhamel, Alain, Lebrun, Frédéric, Mulder, André, Leteurtre, Stéphane
Publicado no Ann Intensive Care (2017)

Inhibition of autophagy as a treatment strategy for p53 wild-type acute myeloid leukemia

Por Folkerts, Hendrik, Hilgendorf, Susan, Wierenga, Albertus T J, Jaques, Jennifer, Mulder, André B, Coffer, Paul J, Schuringa, Jan Jacob, Vellenga, Edo
Publicado no Cell Death Dis (2017)

Azacitidine might be beneficial in a subgroup of older AML patients compared to intensive chemotherapy: a single centre retrospective study of 227 consecutive patients

Por van der Helm, Lieke H, Scheepers, Ellen RM, Veeger, Nic JGM, Daenen, Simon MGJ, Mulder, André B, van den Berg, Eva, Vellenga, Edo, Huls, Gerwin
Publicado em 2013

A single center analysis of nucleophosmin in acute myeloid leukemia: value of combining immunohistochemistry with molecular mutation analysis

Por Woolthuis, Carolien M., Mulder, André B., Verkaik-Schakel, Rikst Nynke, Rosati, Stefano, Diepstra, Arjan, van den Berg, Eva, Schuringa, Jan Jacob, Vellenga, Edo, Kluin, Philip M., Huls, Gerwin
Publicado em 2013